“…For example, data from healthy controls versus a diseased population or from pre-versus post-intervention groups form intuitive background and target pairs. Moreover, with the development of new technologies for measuring cellular responses to large numbers of perturbations in parallel, such as Perturb-Seq [11], MIX-Seq [35], MULTI-Seq [36], and sci-Plex [41] among others, tools for better understanding variations unique to such perturbed cells compared to control populations will be critical.Isolating salient variations present only in a target dataset is the subject of contrastive analysis (CA) [56,3,22,29,40,2,48]. While many recent studies have modeled scRNAseq data by fitting probabilistic models and representing the data in a lower dimension [30,38,18,32,31], few of these models are designed for CA.…”